CompoAtlas

Folic acid 1 mg

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Cellulose microcristalline, Stéarate de magnésium, Hypromellose

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in normal growth and development. A factor in the maintenance of good health. Contributes to maintaining general health. For maintaining general health. Helps to form red blood cells. Helps to maintain/support the body's ability to metabolize nutrients. Helps to prevent folate deficiency. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Helps to support normal early fetal development (brain and spinal cord). Maintains/supports good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Vitamin supplement.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Other names
Western Family Folic acid 1 mg
Licence holder
Pharmaline Inc.
NPN or DIN-HM
80123728
Status
Active licence
Licence date
4 April 2023
Revision date
16 October 2024
Form
Capsule
Route of administration
Orale
Application type
Officinale

Source

Official Health Canada record, licence 80123728

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2024. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line